20540511000001106: Clasteon 800mg tablets (Kent Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)
\UK product\Trade family\Clasteon\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing phosphorus and/or phosphorus compound (product)\Product containing bisphosphonate\Product containing clodronic acid\Product containing only clodronic acid (medicinal product)\Product containing only clodronic acid in oral dose form (medicinal product form)\Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phosphorus and/or phosphorus compound (product)\Product containing bisphosphonate\Product containing clodronic acid\Product containing clodronic acid in oral dose form (medicinal product form)\Product containing only clodronic acid in oral dose form (medicinal product form)\Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing clodronic acid in oral dose form (medicinal product form)\Product containing only clodronic acid in oral dose form (medicinal product form)\Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Product containing bone resorption inhibitor\Product containing bisphosphonate\Product containing clodronic acid\Product containing only clodronic acid (medicinal product)\Product containing only clodronic acid in oral dose form (medicinal product form)\Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Product containing bone resorption inhibitor\Product containing bisphosphonate\Product containing clodronic acid\Product containing clodronic acid in oral dose form (medicinal product form)\Product containing only clodronic acid in oral dose form (medicinal product form)\Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet\Clasteon 800mg tablets (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1858341000001113 Clasteon 800mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1858351000001111 Clasteon 800mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Is a	Product containing precisely clodronate disodium 800 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Clodronate disodium	false	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has specific active ingredient	Clodronate disodium	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Is a	Clasteon	true	Inferred relationship	Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets	Has AMP	True	Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1858341000001113	Clasteon 800mg tablets (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1858351000001111	Clasteon 800mg tablets (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module